ATE202925T1 - Impfpackung enthaltend ein behälter mit gefriertrockenen impfkomponenten - Google Patents

Impfpackung enthaltend ein behälter mit gefriertrockenen impfkomponenten

Info

Publication number
ATE202925T1
ATE202925T1 AT97200647T AT97200647T ATE202925T1 AT E202925 T1 ATE202925 T1 AT E202925T1 AT 97200647 T AT97200647 T AT 97200647T AT 97200647 T AT97200647 T AT 97200647T AT E202925 T1 ATE202925 T1 AT E202925T1
Authority
AT
Austria
Prior art keywords
vaccination
container
freeze
components
dry
Prior art date
Application number
AT97200647T
Other languages
English (en)
Inventor
Antonius Theodorus Wilderbeek
Hans Almer Middelbeek
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE202925T1 publication Critical patent/ATE202925T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
AT97200647T 1996-03-07 1997-03-05 Impfpackung enthaltend ein behälter mit gefriertrockenen impfkomponenten ATE202925T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96200621 1996-03-07

Publications (1)

Publication Number Publication Date
ATE202925T1 true ATE202925T1 (de) 2001-07-15

Family

ID=8223754

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97200647T ATE202925T1 (de) 1996-03-07 1997-03-05 Impfpackung enthaltend ein behälter mit gefriertrockenen impfkomponenten

Country Status (19)

Country Link
US (2) US5897852A (de)
EP (1) EP0799613B1 (de)
JP (1) JP4293643B2 (de)
KR (1) KR100458370B1 (de)
CN (1) CN1133423C (de)
AT (1) ATE202925T1 (de)
AU (1) AU704629B2 (de)
CA (1) CA2198195C (de)
DE (1) DE69705569T2 (de)
DK (1) DK0799613T3 (de)
EG (1) EG23992A (de)
ES (1) ES2161412T3 (de)
GR (1) GR3036725T3 (de)
HU (1) HU220532B1 (de)
IL (1) IL120202A (de)
NZ (1) NZ314267A (de)
PT (1) PT799613E (de)
SA (1) SA97170715B1 (de)
ZA (1) ZA971734B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
AU779403B2 (en) * 1999-08-24 2005-01-20 Teva Pharmaceutical Industries Ltd. A vaccine composition and method of using the same
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof
US6780581B2 (en) 2001-09-12 2004-08-24 Btf Pty Ltd Products comprising quantum of bioparticles and method for production thereof
WO2013034682A1 (en) 2011-09-08 2013-03-14 Umc Utrecht Holding B.V. Vaccine based on staphylococcal superantigen- line 3 protein (ssl3)
MXPA06006896A (es) * 2003-12-19 2006-09-04 Alk Abello As Metodo de criogranulacion y almacenamiento para agentes farmaceuticos activos.
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
TWI436789B (zh) * 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CA2716399C (en) 2008-03-05 2020-07-21 Pierre Chouvenc Process for stabilizing an adjuvant containing vaccine composition
EP2143440A1 (de) * 2008-07-09 2010-01-13 Sanofi Pasteur Stabilisierungssubstanz und Impfzusammensetzung, die ein oder mehrere abgeschwächte lebende Flaviviridae enthält
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
EP2658568A1 (de) 2010-12-29 2013-11-06 Intervet International B.V. Impfstoffantigen von babesiose des hundes
EP2773778B1 (de) 2011-10-31 2020-11-18 Merck Sharp & Dohme Corp. Verfahren zur herstellung kugelförmiger lyophilisierter pellets aus biologischen materialien
WO2017066134A1 (en) * 2015-10-16 2017-04-20 Merck Sharp & Dohme Corp. Processes for preparing formulations for gastrointestinal-targeted therapies
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114159555A (zh) * 2021-12-08 2022-03-11 江西赛基生物技术有限公司 抗原蛋白冻干小球及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
NL174429C (nl) * 1971-09-03 1984-06-18 Du Pont Werkwijze voor het bereiden van gevriesdroogd serum of plasma.
US3857423A (en) * 1971-12-27 1974-12-31 W Ronca Topical medicament kit with interlocking components
US3893280A (en) * 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
US4351158A (en) * 1980-01-22 1982-09-28 American Home Products Corporation Method of producing multicomponent lyophilized product
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IE61575B1 (en) 1987-05-04 1994-11-16 Merck & Co Inc A stable lyophilized live herpes virus vaccine
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
US5044091B1 (en) * 1989-04-18 1997-12-30 Sankyo Co Method of preparing a freeze-dried formulation of a drug
WO1990013285A1 (en) * 1989-05-01 1990-11-15 Enzytech, Inc. Process for producing small particles of biologically active molecules
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
CA2051092C (en) * 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
ATE146360T1 (de) * 1993-04-28 1997-01-15 Akzo Nobel Nv Gonadotropin enthaltende gefriergetrocknete troepfen
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components

Also Published As

Publication number Publication date
ES2161412T3 (es) 2001-12-01
KR970064584A (ko) 1997-10-13
NZ314267A (en) 1998-01-26
HUP9700556A3 (en) 2000-04-28
EG23992A (en) 2008-03-09
DK0799613T3 (da) 2001-10-22
MX9701726A (es) 1998-03-31
CA2198195C (en) 2005-10-25
CN1133423C (zh) 2004-01-07
US5897852A (en) 1999-04-27
PT799613E (pt) 2001-12-28
JP4293643B2 (ja) 2009-07-08
CN1163102A (zh) 1997-10-29
HU220532B1 (hu) 2002-03-28
SA97170715B1 (ar) 2006-10-11
HUP9700556A2 (en) 1997-12-29
IL120202A (en) 2001-03-19
IL120202A0 (en) 1997-06-10
AU1514997A (en) 1997-09-11
DE69705569T2 (de) 2002-05-16
GR3036725T3 (en) 2001-12-31
ZA971734B (en) 1997-09-09
US6106836A (en) 2000-08-22
HU9700556D0 (en) 1997-04-28
AU704629B2 (en) 1999-04-29
EP0799613B1 (de) 2001-07-11
JPH1024090A (ja) 1998-01-27
EP0799613A1 (de) 1997-10-08
DE69705569D1 (de) 2001-08-16
CA2198195A1 (en) 1997-09-07
KR100458370B1 (ko) 2005-07-07

Similar Documents

Publication Publication Date Title
ATE202925T1 (de) Impfpackung enthaltend ein behälter mit gefriertrockenen impfkomponenten
IT8419729A0 (it) Procedimento per la preparazione di vaccini polivalenti adsorbiti liofilizzati.
NO910731D0 (no) Fremgangsmaate for fremstilling av 2-r2-r4-substituert-3-r3-co-1-((c-tilknyttet-n-heteryl)-(alk)n)-1h-indoler.
ATE229978T1 (de) Helicobacter proteine und impstoffe
NO892251D0 (no) Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker.
DE69103699D1 (de) Kasten zur Aufnahme von Flaschen.
DE3889320D1 (de) Härtbare Organopolysiloxanzusammensetzung.
DE59409751D1 (de) Verfahren zur Herstellung von hydroxyphenylsubstituierten 1,3,5-Triazinen
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
DE59409434D1 (de) Verfahren zur Herstellung von Hydroxyphenyl-1,3,5-Triazinen
NO972219D0 (no) Immunogenpreparater
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
NO993533L (no) FremgangsmÕte for stabilisering av peptider, samt frysetörkede medisinske preparater som inneholder peptider erholdt ved Õ anvende fremgangsmÕten
DE59402292D1 (de) Verfahren zur Herstellung von 1,3,5-Triazinen
ES2096988T3 (es) Organopolisiloxanos que contienen grupos hidrofilos.
MX167776B (es) Compuestos volatiles de silicio
DE69300551D1 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
DE69425028D1 (de) Zusammensetzung zur Konservierung von Holzprodukten
AU6278680A (en) Carbamates and pharmaceutical formulations containing them
AU6724581A (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
ATE295182T1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
DE3869656D1 (de) Harzumhuellter mehrchip-modul und verfahren zur herstellung desselben.
ATE235553T1 (de) Protein p100von menschlichem herpesvirus typ 6, die korrespondierenden dns squenzen, ihre herstellung und verwendung
GB2283974A (en) Allatostatins and their use
IT7927018A0 (it) Procedimento per la preparazione di omega-lattami, in particolare caprolattame.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification